Clinical Trials Update:&nbsp;Aug. 25, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
87010
New data are due out on a promising cholesterol drug. But there are doubters.
417456
roundup Plus: .Mac customers suffer e-mail glitches...IBM launches business research group...Verbatim to make discs with HP labeling feature.
5466
MONDAY, Sept. 10 (HealthDay News) -- Little more than one in eight phase II cancer clinical trials with encouraging results go forward to the larger, phase III stage that&#39;s needed to bring a new therapy to patients, a new study finds.
454422
roundup Plus: IBM launches business research group...Verbatim to make discs with HP labeling feature...SWsoft teams with Acronis to boost virtual servers...Dell, Topspin tout InfiniBand clusters.
641201
A preview of some of the biopharmas presenting at the American Society of Clinical Oncology conference.
730807
WASHINGTON - The Food and Drug Administration (news - web sites) will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants.
360951
roundup Plus: Cray signs two supercomputing customers...MSN Messenger beta leaks onto Web...Level 3 to buy Sprint's dial-up business...Cisco CEO's salary shoots up from $1...SanDisk ups capacity on flash memory cards.
612567
THURSDAY, Sept. 6 (HealthDay News) -- New studies from the first annual Breast Cancer Symposium shed light on racial differences in breast cancer, how not sticking with treatment can affect survival, and how nagging side effects cause people to stop their therapies.
594638
roundup Plus: Think local, act Google...SanDisk to supply Samsung with miniSD...Hitachi unleashes 100GB notebook drives.
407096
roundup Plus: Keynote to buy researcher Vividence...Melinda Gates joins Washington Post board...The Woz has got game...Opera browsing, as seen on TV...EdgeStream introduces IPTV platform...Dolby, Intel sound off for developers.
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
459660
roundup Plus: Senate postpones vote on file-swapping bill...HP may expand Puerto Rican research...HP also uses Hitachi drives in servers, storage...Microsoft boosts reporting tools.
122956
Many clinical cancer trials are not published in order to keep industry secrets. A British cancer research group calls for all studies to be published -- even those with marginal results -- so doctors are not misled.
621066
Two newly published studies in the September 17, 2004 issue of Science give rise to the possibility of developing drug therapies that target eosinophils, white blood cells long known to be associated with the asthma.
388102
Pre-clinical trial results are mixed, but mark a major step forward for developing human treatments.
69513
roundup Plus: Sun makes financial pitch...PeopleSoft-Oracle trial delayed...IBM, Boeing team up for defense work.